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Background: The present study describes the tracheorelaxant and anti-inflammatory effects of Polygonatum
verticillatum which may support its medicinal use in hyperactive airway complaints and inflammatory disorders.
Methods: The tracheorelaxant activity of crude extract of the rhizomes of P. verticillatum (PR) was assessed in
isolated guinea-pig tracheal tissues immersed in tissue organ bath filled with Tyrode’s solution and a continuous
supply of carbogen gas (95% O2 and 5% CO2). The contractile and relaxant responses of the tissue were measured
using isometric transducers coupled with Power-Lab data acquisition system. The anti-inflammatory effect was
evaluated in carrageenan-induced rat paw edema model, while the lipoxygenase inhibitory activity was performed
in the in-vitro assay. Various chromatographic and spectroscopic techniques were used for the isolation and
characterization of pure molecules.
Results: In isolated guinea-pig tracheal preparations, PR caused complete inhibition of the high K+ (80 mM) and
carbachol-induced contractions however, it was more potent against K+ than CCh, similar to verapamil.
Pretreatment of the tissue with PR, displaced the Ca2+ concentration-response curves to the right, similar to that
induced by verapamil, indicating the presence of Ca2+ channel blocking like activity. When tested on carrageenan-
induced rat paw edema, PR demonstrated a marked reduction in edema with 65.22% protection at 200 mg/kg,
similar to aspirin. In the in-vitro assay, PR showed lipoxygenase inhibitory activity (IC50: 102 ± 0.19 μg/mL), similar to
baicalein. Bioactivity-guided fractionation led to the isolation of 2-hydroxybenzoic acid and β-sitosterol.
Conclusions: These results indicate that the plant possesses tracheorelaxant, mediated possibly through a Ca2+
channel blockade mechanism, and anti-inflammatory activities, which may explain the medicinal use of this plant in
airway disorders and inflammation.
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β-sitosterolBackground
Polygonatum verticillatum [L.] All. (Nooreallam) belo-
nging to family Liliaceae or Convallariaceae possesses
around 57 species and is commonly found in East Asia,
China and Japan [1,2]. In different traditional systems of
medicine, Polygonatum is popular for its use in pulmo-
nary disorders like asthma and inflammation [3,4], in
addition to its multiple other health benefits such as,
antituberculant, antidiabetic, antihypertensive, diuretic,* Correspondence: hkdr2006@gmail.com
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reproduction in any medium, provided the oranalgesic and antipyretic activities [4,5]. P. verticillatum
has also been studied for its analgesic [6,7], antimalarial
and antioxidant [8], metal accumulant [9], insecticidal
[10], antibacterial [11] and antipyretic [12] activities.
A variety of phytochemical constituents have been iso-
lated from different species of the genus Polygonatum;
primarily: saponins, alkaloids, glycosides, flavonoids and
phytohormones. These groups of compounds show dif-
ferent types of activities. Long chain esters from this
plant exhibit potent tyrosinase inhibition [13], alkaloid,
homoisolflavanone, triterpenoid and steroidal saponin
show profound antimicrobial and anticancer proper-
ties [14-17] and emodin from Polygonatum has shownd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Several compounds have also been isolated from the
rhizomes of P. verticillatum including lectins [19], 5-
hydroxymethyl-2-furaldehyde and diosgenin [8]. There is
no study to the best of our knowledge reporting its
usefulness in hyperactive airways disorders or inflamma-
tion. This study describes the tracheorelaxant and anti-
inflammatory activities of P. verticillatum to provide a
scientific background to its medicinal use in hyperactive
airways complaints like asthma or inflammatory condi-
tions. The in-vivo and in-vitro experimental studies have
been designed, followed by bioactivity-guided isolation
of its secondary metabolites.
Method
Plant material
P. verticillatum (whole plant) was collected from the
District Swat, Khyber Pukhtonkhawa, Pakistan, in July-
Aug 2007. The botanical characterization of the plant
material was executed by the Taxonomy Department of
PCSIR Laboratories Peshawar and a specimen with cata-
logue No: 9970 (PES) was deposited in the herbarium of
PCSIR Laboratories Peshawar.
Plant extraction
Air-shade dried rhizomes of the P. verticillatum (8 kg)
were grounded to a fine powder. The powdered material
was soaked in aqueous-methanol (30:70) for three days
while shaking occasionally [20] and filtered through a
muslin cloth and Whatman filter paper (Maidstone, UK)
simultaneously. This procedure was repeated three times
and all the pooled filtrates were evaporated on a rotary
evaporator (model RE-111, Buchi, Flawil, Switzerland)
under reduced pressure (−760 mm Hg) to obtain a dark
greenish semi-solid material, yielding 27.50 wt/wt%.
Experimental animals
A total of thirty Wistar rats (190–260 g) and five adult
local guinea-pigs (1.2 − 1.6 kg) of either sex were kept
under standard laboratory conditions at 25 ± 2°C and a
relative humidity of 40-70%. The light cycle was main-
tained as 12 h dark: 12 h light. They were fed with a
laboratory diet ad libitum and allowed free access to
drinking water. All the experiments were performed in
compliance with the rulings of the Institute of Labora-
tory Animal Resources, Commission on Life Sciences,
National Research Council [21] and approved by the
local Ethical Committee of the Karachi University.
Drugs and reagents
Carrageenan, carbachol (CCh), verapamil hydrochloride,
soybean lipoxygenase, linoleic acid sodium salt and
baicalein were purchased from the Sigma Chemicals Co.,
St. Louis, MO, USA and aspirin was obtained from theReckitt & Colman, Pakistan. Chemicals used for mak-
ing Tyrode’s solution were: potassium chloride (Sigma
Chemicals Co., St. Louis, MO, USA), calcium chloride,
glucose, magnesium chloride, sodium bicarbonate, sodium
dihydrogen phosphate (Merck, Darmstadt, Germany) and
sodium chloride from BDH Laboratory supplies, Poole,
England. All chemicals used were of highest grade avai-
lable, and were solubilized in distilled water/saline while
carrageenan was used as suspension with acacia.
Isolated guinea-pig tracheal tissue
The trachea was obtained from guinea-pigs and pre-
served in physiological solution (Kreb’s solution). Rings
containing a couple of cartilages were formed from a
tracheal tube approximately 2–3 mm wide. Rings were
cut into strips by a longitudinal cut on the ventral side
reverse to the smooth muscle [22]. The strips were
suspended in a tissue bath (20 mL) containing Kreb’s
solution (pH 7.4), maintained at 37°C and aerated
with a mixture of 95% oxygen and 5% carbon dioxide
(carbogen). Tracheal strips were maintained at 1 gram
constant tension during the course of experiment. The
tissues were granted 1 h to equilibrate prior to the intro-
duction of test material. Before determining the inhibi-
tory activity of the plant extract, the isolated tracheal
tissues were stabilized with high K+ (80 mM) and CCh
(1 μM) until constant responses of each agonist were
achieved (usually 3–4 concentrations). The sustained
contractions were obtained using CCh and K+ separately
and the inhibitory effect was assessed using the cumula-
tive addition of the test material. Isometric responses
were recorded on a Grass model 7 Polygraph (Grass in-
strument company, Quincy, MA, USA). The inhibition
of the high K+-induced contractions indicates Ca2+ antag-
onist activity [23], which was confirmed by constructing
the Ca2+ concentration-response curves in the absence
and presence of increasing concentrations of the plant
material.
Carrageenan-induced edema
The carrageenan-induced rat hind paw edema test was
conducted as described previously [24]. The test animals
were divided in to five groups (n = 6). Group Ι (the con-
trol group) received normal saline (10 mL/kg). The rats
of group ΙΙ, ΙΙΙ and ΙV received the test extract (50, 100
or 200 mg/kg i.p.), while, group V (positive control)
received aspirin (100 mg/kg i.p.). Following 30 min of
the treatments, acute inflammation was induced by sub-
plantar injection of 0.1 mL of 1% suspension of carra-
geenan with 2% gum acacia in normal saline, in the right
hind paw of the rats. The paw volume was estimated
with the help of plethysmometer (Ugo Basile, Italy) at
1st, 2nd, 3rd, 4th and 5th h after the carrageenan injection.
Statistics was applied on the raw data for the calculation
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against saline, followed by the calculation of percent re-
duction in the rat paw using the following formula:
% inhibition ¼ 1 dt=dcð Þ  100
where “dt” is the difference in paw volume in the treated
group and “dc” the difference in paw volume in the con-
trol group.
Soybean lipoxygenase inhibitory assay
The lipoxygenase (LOX) inhibition assay was conducted
by using different dilutions of the PR by following previ-
ously described method [25]. Soybean lipoxygenase and
linoleic acid were used. Equal volume (10 mL) of the
sample (PR) and standard drug along with 20 mL of
solvent lipoxygenase solution simultaneously were mixed
followed by incubation for 5 min at 25°C. The bioche-
mical reaction was initiated by the addition of linoleic
acid solution (10 μL) as substrate and the absorption
change with the formation of (9Z,11E)-13S)-13-hydro-
peroxyoctadeca-9, 11-dienoate was followed for 10 min
at 234 nm. The test sample and the control were dis-
solved in 50% ethanol. All the reactions were performed
in triplicate. Baicalein was used as a positive control.
The median effective concentrations (IC50 values) were
calculated using the EZ-Fit Enzyme Kinetics program
(Perrella Scientific Inc., Amherst, USA).
Isolation of pure molecules
A sample of 80 g of the aqueous-methanol extract of P.
verticillatum rhizomes (PR) was subjected to column
chromatography over silica gel (column grade) for the
isolation of pure chemical compounds. The sample was
loaded in a glass column over silica gel for adsorption
that acts as stationary phase. The column was initiated
with 100% n-Hexane as eluent (mobile phase). Polarity
of mobile phase was enhanced gradually with regular
monitoring of the isolate status over TLC, it resulted in
12 sub-fractions (P1-P12). Similar with methanol/chloro-
form gradient, 9 subfractions (M1-M9) were obtained.
When sub-fraction P9 was purified through column
chromatography, 2-Hydroxybenzoic acid (A) was iso-
lated in the colorless crystals form (1A). Subfraction P11
was re-chromatographed over silica gel. While eluting
with chloroform: hexane; (8:2), β-Sitosterol (B) was iso-
lated as colorless amorphous powder (1B).
Characterization of 2-Hydroxybenzoic acid (A)
Colorless crystals, M.P. 159-160°C, HREIMS: m/z 138
(Calcd. for C7H6O3; 138.12),
1H NMR (CHCl3, 300 MHz):
δ 6.89 broad d (J = 8.4 Hz), 7.42 dt (J = 1.8, 8.4 Hz), 6.85 t
(J = 7.8 Hz), 7.83 dd (J = 1.8, 8.4), 13C NMR (CDCl3,75 MHz): δ 113.9 (C-1), 163.2 (C-2), 118.1 (C-3), 136.6
(C-4), 120.0 (C-5), 131.5 (C-6), 173.5 (C-1′).
Characterization of β-sitosterol (B)
Colourless amorphous powder, M.P. 135-136°C, HREIMS:
m/z 414.3845 (calculated for C29H50O as 414.3855).
1H NMR (CHCl3, 300 MHz): δ 3.65 (m), 5.35 (m), 0.67 (s),
0.99 (s), 0.91 d (J = 6.3 Hz), 0.83 d (J = 6.8 Hz), 0.79 d
(J = 6.8 Hz), 0.82 t (J = 7.0 Hz). 13C NMR (CDCl3,
75 MHz): δ 37.1 (C-1), 31.6 (C-2), 72.1 (C-3), 42.4 (C-4),
139.5 (C-5), 120.0 (C-6), 32.5 (C-7), 35.3 (C-8), 49.8 (C-9),
36.2 (C-10), 22.1 (C-11), 40.3 (C-12), 43.1 (C-13), 56.9
(C-14), 24.7 (C-15), 27.9 (C-16), 54.7 (C-17), 12.1 (C-18),
18.7 (C-19), 40.1 (C-20), 21.5 (C-21), 33.8 (C-22), 28.8
(C-23), 50.5 (C-24), 26.7 (C-25), 18.9 (C-26), 21.5 (C-27),
23.1 (C-28), 12.6 (C-29).
Statistical analysis
Results obtained from the pharmacological experiments
are expressed as mean values ± S.E.M. One-way ANOVA
test was employed for comparison of the significant dif-
ferences among the groups followed by Dunnet’s mul-
tiple comparison post-test. A probability of P < 0.05 was
considered as significant. Concentration–response curves
were analyzed by nonlinear regression using GraphPad
program (GraphPAD, San Diego, CA, USA).
Results
Effect of PR on guinea-pig tracheal tissue
When PR was studied for its inhibitory effect against
high K+ (80 mM) and CCh (1 μM) induced contractions
in guinea-pig tracheal preparations, it caused inhibitory
effects at the dose range of 0.01-10 mg/mL in a dose-
dependent manner with greater potency against K+
(Figure 1a), similar to that of verapamil, which exhibited
relaxation at the dose range of 0.03-3 μM (Figure 1c).
To confirm the Ca2+ antagonist-like effect, the concen-
tration-response curves (CRCs) of Ca2+ were construc-
ted in the absence and presence of different doses of the
plant extract, in Ca2+-free and K+ rich medium. Pretreat-
ment of PR at the doses of 0.03 and 0.1 mg/mL,
displaced the CRCs of Ca2+ to the right with suppression
of the maximum response (Figure 1b), similar to that
caused by verapamil, which also displaced the Ca2+
CRCs to the right with suppression of the maximum res-
ponse at tested doses of 0.003 and 0.01 μM (Figure 1d).
Effects of PR on carrageenan-induced rat paw edema
PR demonstrated marked reduction (P < 0.01) in edema
showing anti-inflammatory activity at the test doses of
50, 100 and 200 mg/kg, similar to that caused by aspirin
(Table 1). The data show that the effect is dose and
time-dependent with a peak effect obtained after 3 h of
Figure 1 Dose-dependent inhibitory effect of the aqueous-methanol extract of P. verticillatum Rhizomes, PR (a) and verapamil (c) on
carbachol (CCh) and K+ (80 mM)-induced contractions, and the dose–response curves of Ca2+ created in the absence and presence of
increasing concentrations of PR (b) and verapamil (d) in isolated guinea-pig jejunum preparation. Data stand for mean ± SEM of 3–5
different experimental findings.
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of aspirin.
Effect of PR on lipoxygenase activity
When tested for inhibition of soybean lipoxygenase by
the UV absorbance based enzyme assay, PR showed a
significant activity against lipoxygenase with resultant
IC50 value of 102 ± 0.19 μg/mL (mean ± SEM, n = 3)Table 1 Anti-inflammatory effect of the aqueous-methanol ex
carrageenan-induced hind paw edema in rats
Group Dose
mg/kg
Increase in paw volume (Mean ± SEM) in mL
1 h 2 h 3
Saline 10 0.70 ± 0.031 0.69 ± 0.040 0.
PR 50 0.64 ± 0.045 (08.57%) 0.61 ± 0.054 (11.59%) 0.
100 0.56 ± 0.036 (20.00%) 0.50 ± 0.049* (27.53%) 0.
200 0.47 ± 0.040* (32.86%) 0.35 ± 0.067** (49.27%) 0.
Aspirin 100 0.23 ± 0.040** (67.14%) 0.19 ± 0.017** (72.46%) 0.
Experimental data are expressed as mean ± S.E.M. for group of at least six animals.
among groups followed by Dunnett’s multiple comparison post-test. A probability o
is shown in parenthesis.compared with that of the standard drug, baicalaim
(22.6 ± 0.09 μg/mL, n = 3).
Isolation of pure molecules
The structures of isolated molecules, 2-hydroxybenzoic
acid (a) and β-sitosterol (b) were confirmed by mass and
NMR spectral data available in literature [26,27] and
shown in Figure 2.tract of P. verticillatum Rhizomes (PR) in
h 4 h 5 h
69 ± 0.049 0.70 ± 0.067 0.72 ± 0.053
55 ± 0.049 (20.29%) 0.54 ± 0.053 (22.85%) 0.55 ± 0.049 (23.61%)
37 ± 0.058** (46.37%) 0.39 ± 0.062** (44.29%) 0.47 ± 0.062* (34.72%)
24 ± 0.045** (65.22%) 0.31 ± 0.053** (55.71%) 0.34 ± 0.062** (52.78%)
17 ± 0.031** (78.1%) 0.18 ± 0.022** (75.71%) 0.18 ± 0.036** (75.00%)
One- way ANOVA was utilized as judgment test of significant differences
f *P < 0.05 or **P < 0.01 was considered significant from control. Protection (%)
Figure 2 Structures of isolated compounds (a) 2-hydroxybenzoic acid, (b) β-sitosterol.
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In view of its medicinal use in hyperactive airway disor-
dered like bronchial spasms and asthma [3], P. verti-
cillatum has been studied for its myorelaxant activity
using isolated guinea-pig tracheal tissue preparations.
While on the basis of its folk reputation as an anti-
inflammatory remedy [4], the plant has been tested for its
anti-inflammatory potential using carrageenan-induced
rat paw edema model.
When test for tracheorelaxant activity, P. verticillatum
caused relaxation of high K+ and CCh-induced contrac-
tions in isolated guinea-pig tracheal tissues with greater
potency against K+. The smooth muscle contraction of
different body systems including the airways depends
upon an increase in the cytoplasmic free Ca2+, which
activates the cellular contractile machinery. The in-
crease in intracellular Ca2+ is due to either influx via
voltage-dependent Ca2+ channels (VDCs) or release from
intracellular stores in the sarcoplasmic reticulum. At con-
centrations higher than 30 mM, K+ is known to causesmooth muscle contractions through the opening of
VDCs, consequently allowing inward movement of
extracellular Ca2+ originating a contractile effect; thus,
a substance causing inhibition of high K+ -induced con-
traction is considered as an inhibitor of Ca2+ influx [23].
Similar to the pattern of inhibitory effect of verapamil, a
standard Ca2+ antagonist [28], against K+ and CCh, a sub-
stance causing inhibition of high K+ at low concentrations
than its effect on CCh, may indicate the presence of
Ca2+ antagonist-like spasmolytic mechanism. To confirm
the Ca2+ antagonist-like effect of P. verticillatum, the
concentration-response curves (CRCs) of Ca2+ were cons-
tructed in the absence and presence of different doses of
the plant extract, where it displaced the CRCs of Ca2+ to
the right with suppression of the maximum response simi-
lar to the effect produced by verapamil, thus attesting the
presence Ca2+ antagonist-like constituents in the plant
extract. The Ca2+ antagonists are known to possess the-
rapeutic potential in the management of hyperactive air-
ways disorders [29,30]. Thus, the Ca2+ antagonist effect
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the plant in airways disorders, though additional mecha-
nism cannot be ruled out.
The carrageenan-induced paw edema test is a well-
established animal model of inflammation used to detect
the anti-inflammatory activity of test materials [25]. It
has been observed that the local edema is induced by
the sub-plantar injection of carrageenan that increases
progressively. Edema formation due to carrageenan in-
jection in the rat paw is the biphasic event during 1–5 h;
the initial phase (1 to 1.5 h) is predominately a non-
phagocytic edema followed by a second phase with in-
creased edema formation that persists up to 5 h [31,32].
Different mediators are known to be involved in diffe-
rent stages of carrageenan-induced edema. The initial
phase (up to 1.5 h) is attributed to the release of his-
tamine, 5-hydroxytryptamine, bradykinin, platelet ac-
tivating factor and serotonin. Kinins (bradykinin and
kallikrein) are involved in both stages, and get released
from 1.5 to 2.5 h and at the last step inflammation is
continued until 5 h due to the release of lipid derived
eicosanoids (prostaglandins, leukotrienes, hydroperoxy-
eicosatetraenoic acid). A comprehensive phagocytic in-
flammation is observed at 3rd h followed by carrageenan
injection with large number of neutrophils and tissue
edema [25,31]. Our results showed significant (P < 0.01)
inhibition in carrageenan-induced paw edema model at
all test doses of anti-inflammatory activity of P. ver-
ticillatum with maximum effect at 3rd h. The observed
anti-inflammatory activity provides an evidence to the
folkloric use of P. verticillatum in inflammation.
Leukotrienes (LTs) are the downstream products of
arachidonic acid that exert pivotal biological functions
as well as pathogenic effects in a wide range of inflam-
matory processes. Polymorphonuclear leukocytes and
monocytes/macrophages are the major cells capable of
synthesizing LTs due to a high 5-Lipoxygenase activity
and represent crucial components in chronic inflamma-
tory diseases [33-35]. The role of lipoxygenase is also
documented in carrageenan provoked edema [33]. Inhib-
ition of lipoxygenase activity results in down regulation
of the pro-inflammatory activity of leukocytes and plate-
lets [36], which may cause a diminished or delayed out-
come of the inflammatory reaction. From a mechanistic
point of view, PR elicited marked inhibitory activity in
soybean lipoxygenase assay.
Phytochemically, the isolation of 2-hydroxybenzoic
acid and β-sitosterol strengthened our findings in a way
that the anti-inflammatory and antioxidant potential of
these compounds have been previously investigated
[37-39]; the effect of 2-hydroxybenzoic acid is known to
be mediated through lipoxygenase (LOX)/cyclooxygen-
ase (COX) inhibition [40,41]. Keeping this in view, it can
also be speculated that the mechanism underlying theanti-inflammatory activity of P. verticillatum is at least
in part due to LOX/COX inhibition, however the ad-
ditional mechanism cannot be ruled out which may be
responsible for the effectiveness of this plant in hyper-
active airways disorders.
Free radical generation plays a pivotal role in the
pathophysiology of inflammatory and airways disorders
[42,43]. P. verticillatum is known to possess strong anti-
oxidant activity [8], which is likely to complement the
anti-inflammatory potential of this plant. Similarly, β-
sitosterol is known to possess the Ca2+ channel blocking
activity [22], which is again consistent with our findings,
showing Ca2+ antagonist activity of P. verticillatum.
There is paucity in traditional literature regarding
exact dose of the plant recommended to be used in air-
ways disorders or as an external anti-inflammatory agent;
however, the observed effective doses were selected on the
basis of our experience of studying the possible mode of
actions of natural remedies for their effectiveness in air-
ways disorders and inflammatory conditions [12,44-46].
Conclusions
These data indicate that P. verticillatum possesses tra-
cheorelaxant, mediated possibly through the Ca2+ chan-
nel blockade and anti-inflammatory activities, which
may explain the medicinal use of this plant in airway
disorders and inflammatory complaints. However, de-
tailed studies are warranted to ascertain the clinical sig-
nificance of this natural product.
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